Validation of the Society for Vascular Surgery Appropriate Use Criteria for management of intermittent claudication
Open Access
- 3 February 2026
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (6) , 1680-1687.e1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: Focused updateJournal of Vascular Surgery, 2025
- Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD RegistryJournal of Interventional Cardiology, 2022
- Society for Vascular Surgery appropriate use criteria for management of intermittent claudicationJournal of Vascular Surgery, 2022
- Medical optimization of the peripheral artery disease patientSeminars in Vascular Surgery, 2022
- Cost Effectiveness of Endovascular Revascularisation vs. Exercise Therapy for Intermittent Claudication Due to Iliac Artery ObstructionEuropean Journal of Vascular and Endovascular Surgery, 2022
- Outcomes of bypass and endovascular interventions for advanced femoropopliteal disease in patients with premature peripheral artery diseaseJournal of Vascular Surgery, 2021
- Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation ratesJournal of Vascular Surgery, 2021
- Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart AssociationCirculation, 2021
- Implementation of Supervised Exercise Therapy for Patients With Symptomatic Peripheral Artery Disease: A Science Advisory From the American Heart AssociationCirculation, 2019
- Medical Treatment of Peripheral Arterial Disease and ClaudicationNew England Journal of Medicine, 2001